A detailed history of Nan Fung Group Holdings LTD transactions in Geron Corp stock. As of the latest transaction made, Nan Fung Group Holdings LTD holds 1,373,550 shares of GERN stock, worth $5.03 Million. This represents 6.07% of its overall portfolio holdings.

Number of Shares
1,373,550
Previous 1,373,550 -0.0%
Holding current value
$5.03 Million
Previous $5.82 Million 7.08%
% of portfolio
6.07%
Previous 6.77%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$3.1 - $5.09 $151,900 - $249,410
49,000 Added 3.7%
1,373,550 $5.82 Million
Q1 2024

May 14, 2024

BUY
$1.75 - $3.44 $719,250 - $1.41 Million
411,000 Added 44.99%
1,324,550 $4.37 Million
Q4 2023

Feb 13, 2024

BUY
$1.74 - $2.31 $278,400 - $369,600
160,000 Added 21.23%
913,550 $1.93 Million
Q3 2023

Nov 13, 2023

BUY
$2.11 - $3.28 $771,310 - $1.2 Million
365,550 Added 94.21%
753,550 $1.6 Million
Q2 2023

Aug 11, 2023

BUY
$1.97 - $3.69 $764,360 - $1.43 Million
388,000 New
388,000 $1.25 Million

Others Institutions Holding GERN

About GERON CORP


  • Ticker GERN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 377,819,008
  • Market Cap $1.38B
  • Description
  • Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...
More about GERN
Track This Portfolio

Track Nan Fung Group Holdings LTD Portfolio

Follow Nan Fung Group Holdings LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nan Fung Group Holdings LTD, based on Form 13F filings with the SEC.

News

Stay updated on Nan Fung Group Holdings LTD with notifications on news.